Nifedipine
Product Images NDC 50090-4249

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50090-4249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Image 01)

FDA Label Image

Image2 (Image 02)

A data table showing mean reductions in trough supine blood pressure (systolic/diastolic, mmHg) for Nifedipine extended-release (ER) tablets at doses of 30 mg, 60 mg, and 90 mg in two studies. Each study lists the number of subjects (N) and corresponding mean trough blood pressure reduction values after placebo response subtracted.*

FDA Label Image

Image3 (Image 03)

A data table comparing the percentage of adverse effects reported in clinical studies between nifedipine extended-release tablets (n=370) and placebo (n=126). Effects listed include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation, with numeric values for each group.*

FDA Label Image

Label Image (Lbl500904249)

Nifedipine 30 mg extended-release film-coated tablets packaging label from A-S Medication Solutions. The label includes storage instructions, lot number, quantity of 30 tablets, package NDC 50090-4249-0, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.